Countering the Problem of Falsified and Substandard Drugs:
Gespeichert in:
Körperschaft: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Washington, D.C.
National Academies Press
2013
|
Schlagworte: | |
Beschreibung: | Description based on publisher supplied metadata and other sources |
Beschreibung: | 1 online resource (377 pages) |
ISBN: | 9780309269407 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV044184838 | ||
003 | DE-604 | ||
005 | 20210705 | ||
007 | cr|uuu---uuuuu | ||
008 | 170220s2013 |||| o||u| ||||||eng d | ||
020 | |a 9780309269407 |9 978-0-309-26940-7 | ||
035 | |a (ZDB-30-PAD)EBC3564286 | ||
035 | |a (ZDB-89-EBL)EBL3564286 | ||
035 | |a (ZDB-38-EBR)ebr10863743 | ||
035 | |a (OCoLC)839275199 | ||
035 | |a (DE-599)BVBBV044184838 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
082 | 0 | |a 364.1668 | |
110 | 2 | |a Institute of Medicine (Washington, DC) |b Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products |e Verfasser |4 aut | |
245 | 1 | 0 | |a Countering the Problem of Falsified and Substandard Drugs |
264 | 1 | |a Washington, D.C. |b National Academies Press |c 2013 | |
264 | 4 | |c © 2013 | |
300 | |a 1 online resource (377 pages) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Description based on publisher supplied metadata and other sources | ||
650 | 4 | |a Fraud -- Prevention | |
650 | 4 | |a Pharmaceutical industry -- Quality control | |
700 | 1 | |a Buckley, Gillian J. |e Sonstige |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-0-309-26939-1 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products |t Countering the Problem of Falsified and Substandard Drugs |
912 | |a ZDB-30-PAD |a ZDB-30-PBE | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-029591629 |
Datensatz im Suchindex
_version_ | 1804177312104579072 |
---|---|
any_adam_object | |
author_corporate | Institute of Medicine (Washington, DC) Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products |
author_corporate_role | aut |
author_facet | Institute of Medicine (Washington, DC) Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products |
author_sort | Institute of Medicine (Washington, DC) Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products |
building | Verbundindex |
bvnumber | BV044184838 |
collection | ZDB-30-PAD ZDB-30-PBE |
ctrlnum | (ZDB-30-PAD)EBC3564286 (ZDB-89-EBL)EBL3564286 (ZDB-38-EBR)ebr10863743 (OCoLC)839275199 (DE-599)BVBBV044184838 |
dewey-full | 364.1668 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 364 - Criminology |
dewey-raw | 364.1668 |
dewey-search | 364.1668 |
dewey-sort | 3364.1668 |
dewey-tens | 360 - Social problems and services; associations |
discipline | Rechtswissenschaft |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01617nmm a2200385zc 4500</leader><controlfield tag="001">BV044184838</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210705 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170220s2013 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309269407</subfield><subfield code="9">978-0-309-26940-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC3564286</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL3564286</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-38-EBR)ebr10863743</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)839275199</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044184838</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">364.1668</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (Washington, DC)</subfield><subfield code="b">Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Countering the Problem of Falsified and Substandard Drugs</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">2013</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (377 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fraud -- Prevention</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry -- Quality control</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buckley, Gillian J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-0-309-26939-1</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products</subfield><subfield code="t">Countering the Problem of Falsified and Substandard Drugs</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield><subfield code="a">ZDB-30-PBE</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029591629</subfield></datafield></record></collection> |
id | DE-604.BV044184838 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:46:04Z |
institution | BVB |
isbn | 9780309269407 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029591629 |
oclc_num | 839275199 |
open_access_boolean | |
physical | 1 online resource (377 pages) |
psigel | ZDB-30-PAD ZDB-30-PBE |
publishDate | 2013 |
publishDateSearch | 2013 |
publishDateSort | 2013 |
publisher | National Academies Press |
record_format | marc |
spelling | Institute of Medicine (Washington, DC) Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products Verfasser aut Countering the Problem of Falsified and Substandard Drugs Washington, D.C. National Academies Press 2013 © 2013 1 online resource (377 pages) txt rdacontent c rdamedia cr rdacarrier Description based on publisher supplied metadata and other sources Fraud -- Prevention Pharmaceutical industry -- Quality control Buckley, Gillian J. Sonstige oth Erscheint auch als Druck-Ausgabe 978-0-309-26939-1 Erscheint auch als Druck-Ausgabe Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products Countering the Problem of Falsified and Substandard Drugs |
spellingShingle | Countering the Problem of Falsified and Substandard Drugs Fraud -- Prevention Pharmaceutical industry -- Quality control |
title | Countering the Problem of Falsified and Substandard Drugs |
title_auth | Countering the Problem of Falsified and Substandard Drugs |
title_exact_search | Countering the Problem of Falsified and Substandard Drugs |
title_full | Countering the Problem of Falsified and Substandard Drugs |
title_fullStr | Countering the Problem of Falsified and Substandard Drugs |
title_full_unstemmed | Countering the Problem of Falsified and Substandard Drugs |
title_short | Countering the Problem of Falsified and Substandard Drugs |
title_sort | countering the problem of falsified and substandard drugs |
topic | Fraud -- Prevention Pharmaceutical industry -- Quality control |
topic_facet | Fraud -- Prevention Pharmaceutical industry -- Quality control |
work_keys_str_mv | AT instituteofmedicinewashingtondccommitteeonunderstandingtheglobalpublichealthimplicationsofsubstandardfalsifiedandcounterfeitmedicalproducts counteringtheproblemoffalsifiedandsubstandarddrugs AT buckleygillianj counteringtheproblemoffalsifiedandsubstandarddrugs |